DK285589D0 - Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi - Google Patents

Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi

Info

Publication number
DK285589D0
DK285589D0 DK285589A DK285589A DK285589D0 DK 285589 D0 DK285589 D0 DK 285589D0 DK 285589 A DK285589 A DK 285589A DK 285589 A DK285589 A DK 285589A DK 285589 D0 DK285589 D0 DK 285589D0
Authority
DK
Denmark
Prior art keywords
oxochinazoline
hyperlipidaemia
derivatives
preparation
medicine against
Prior art date
Application number
DK285589A
Other languages
English (en)
Other versions
DK285589A (da
Inventor
Gerhard Rauber
Roland Stechert
Kurt Schromm
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of DK285589A publication Critical patent/DK285589A/da
Publication of DK285589D0 publication Critical patent/DK285589D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK285589A 1987-10-15 1989-06-12 Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi DK285589D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873734909 DE3734909A1 (de) 1987-10-15 1987-10-15 Verwendung von oxochinazolinderivaten bei der behandlung der hyperlipidaemie
PCT/EP1988/000918 WO1989003215A1 (en) 1987-10-15 1988-10-12 Use of oxoquinazoline derivatives for the treatment of hyperlipidemia

Publications (2)

Publication Number Publication Date
DK285589A DK285589A (da) 1989-06-12
DK285589D0 true DK285589D0 (da) 1989-06-12

Family

ID=6338388

Family Applications (1)

Application Number Title Priority Date Filing Date
DK285589A DK285589D0 (da) 1987-10-15 1989-06-12 Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi

Country Status (7)

Country Link
EP (2) EP0346408A1 (da)
JP (1) JPH01132520A (da)
KR (1) KR890701106A (da)
DE (1) DE3734909A1 (da)
DK (1) DK285589D0 (da)
HU (1) HUT53289A (da)
WO (1) WO1989003215A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT63629A (en) * 1992-03-03 1993-09-28 Sandoz Ag Process for producing substituted phenylquinazoline derivatives and pharmaceutical compositions comprising same
EP4259628A2 (de) * 2020-12-10 2023-10-18 Merck Patent GmbH Materialien für organische elektrolumineszenzvorrichtungen
PT119467A (pt) * 2024-05-17 2025-11-17 Inst Superior Tecnico Método implementado por computador para avaliação da gravidade de uma estenose coronária em repouso ou sob hiperemia

Also Published As

Publication number Publication date
DK285589A (da) 1989-06-12
JPH01132520A (ja) 1989-05-25
EP0346408A1 (de) 1989-12-20
HU886315D0 (en) 1990-09-28
HUT53289A (en) 1990-10-28
WO1989003215A1 (en) 1989-04-20
EP0312076B1 (de) 1991-09-25
KR890701106A (ko) 1989-12-19
DE3734909A1 (de) 1989-04-27
EP0312076A1 (de) 1989-04-19

Similar Documents

Publication Publication Date Title
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
FI884914A7 (fi) Uusia insuliinijohdannaisia
DK195690A (da) Anvendelse af coumarinderivater til fremstilling af et laegemiddel mod human immundefekt-virus
DK407588D0 (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse
NO891906L (no) Fremgangsmaate for fremstilling av et harpiksadsorbat av ranitidin.
DK158770C (da) Anvendelse af paroxetin til fremstilling af medikament mod fedme
NO170079C (no) Fremgangsmaate for fremstilling av et krystallinsk torasemid
DK349387A (da) Nitrofuranderivater samt fremgangsmaade til fremstilling deraf og anvendelse af forbindelserne som laegemiddel
DK160739C (da) Fremgangsmaade til fremstilling af et stabilt prostaglandinindeholdende praeparat til laegemiddelanvendelse
PT91631A (pt) A process for the preparation of cyclic graf-analogs ii
DK615988D0 (da) Fremgangsmaade til fremstilling af et afsvovlingsmiddel
DK313989D0 (da) Farmaceutisk praeparat mod atherosclerose
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NO870866D0 (no) Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat.
DK128589A (da) Anvendelse af piperidinmethanolderivater til fremstilling af et farmaceutisk praeparat
DK689188D0 (da) Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat
DK473288D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473088D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK95489D0 (da) Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel
DK285589A (da) Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi
NO171581C (no) Fremgangsmaate for fremstilling av et soppsmaksmiddel
DK265789A (da) Fremstilling af et farmaceutisk praeparat
DK651588D0 (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
DK341188D0 (da) Fremgangsmaade til fremstilling af en vaeskeabsorberende pude
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment